Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American Joint Committee on cancer staging

Journal of Clinical Oncology

Volumn 22, Issue 18, 2004, Pages 3668-3676

  Gimotty, Phyllis A ^a   Guerry, DuPont ^a   Ming, Michael E ^a   Elenitsas, Rosalie ^a   Xu, Xiaowei ^a   Czerniecki, Brian ^a   Spitz, Francis ^a   Schuchter, Lynn ^a   Elder, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MITOSIS RATE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; AGED; CANCER INVASION; CLASSIFICATION; DECISION TREE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SKIN TUMOR; STANDARD;

AGED; DECISION TREES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 4644324543     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.12.015     Document Type: Article

References (37)

1. Surveillance. Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Public-Use Data (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission.
2. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001
3. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on caner staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648, 2001
4. Clark WH, Elder DE, Guerry D, et al: Model predicting survival in Stage I melanoma based on tumor progression. JNCI 81:1893-1904, 1989
5. Greene F, Page D, Fleming I, et al: AJCC Cancer Staging Handbook Sixth Edition, New York, NY, Springer, 2002
6. Schuchter L, Schultz DJ, Synnestvedt M, et al: A prognostic model for predicting 10-year survival in patients with primary melanoma: The Pigmented Lesion Group. Ann Intern Med 125: 369-375, 1996
7. Sahin S, Rao B, Kopf AW, et al: Predicting ten-year survival of patients with primary cutaneous melanoma. Cancer 80:1426-1431, 1997
8. Averbook BJ, Fu P, Rao JS, et al: A long-term analysis of 1018 patients with melanoma by Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. Surgery 132:589-604, 2002
9. Garbe C, Buttner P, Bertz J, et al: Primary cutaneous melanoma: Indentification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 75:2484-2491, 1995
10. Huang X, Soong S, McCarthy WH, et al: Classification of localized melanoma by the exponential survival trees method. Cancer 79: 1122-1128, 1997
11. Dong XD, Tyler D, Johnson JL, et al: Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer 88: 1063-1071, 2000
12. Beahrs OH, Henson DE, Hutter RVP, et al: American Joint Committee on Cancer manual for staging cancer. Philadelphia, PA, JB Lippincott, 1988
13. SAS Institute Inc: SAS/STAT User's Guide, Version 8, Cary, NC, SAS Institute Inc, 1999
14. Steinberg D, Colla P: CART: Tree-structured non-parametric data analysis, San Diego, CA, Salford Systems, 1995
15. Bedrosian I, Faries MB, Guerry D, et al: Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase. Ann Surg Oncol 7:262-267, 2000
16. Elder DE, Guerry D, Epstein MN, et al: Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol 6:55-61, 1984 (suppl)
17. Guerry D, Synnestvedt M, Elder DE, et al: Lessons from tumor progression: The invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol 100:342S-345S, 1993
18. Wyatt JC, Altman DG: Commentary: Prognostic models: Clinically useful or quickly forgotten? BMJ 311:1539-1541, 1995
19. National Institutes of Health: Consensus Development Conference: Diagnosis and treatment of early melanoma. JAMA 268:1314-1319, 1992
20. McKinnon JG, Yu XQ, McCarthy WH, et al: Prognosis for patients with thin cutaneous melanoma. Cancer 98:1223-1231, 2003
21. Mansson-Brahme E, Carstensen J, Erhardt K, et al: Prognostic factors in thin cutaneous malignant melanoma. Cancer 73:2324-2332, 1994
22. Finley JW, Gibbs JF, Rodriguez LM, et al: Pathologic and clinical features influencing outcome of thin cutaneous melanoma: Correlation with newly proposed staging system. Am Surg 66:527-531, 2000
23. Oliveira Filho RS, Ferreira LM, Biasi LJ, et al: Vertical growth phase and positive sentinel node in thin melanoma. Braz J Med Biol Res 36:347-350, 2003
24. Gromet MA, Epstein WL, Blois MS: The regressing thin malignant melanoma: A distinctive lesion with metastatic potential. Cancer 42: 2282-2292, 1978
25. Cook MG, Spatz A, Brocker E, et al: Identification of histological features associated with metastatic potential of thin (< 1.0 mm) cutaneous melanoma with metastases: A study on behalf of the EORTC Melanoma Group. J Pathol 197:188-193, 2002
26. Lefevre M, Vergier B, Balme B, et al: Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol 27:717-724, 2003
27. Massi D, Franchi A, Borgognoni L, et al: Thin cutaneous malignant melanomas (< or = 1.5 mm): Identification of risk factors indicative of progression. Cancer 85:1067-1076, 1999
28. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology: CRC Melanoma Pathology Panel. J Clin Pathol 50:202-205, 1997
29. McDermott NC, Hayes DP, al-Sader MH, et al: Identification of vertical growth phase in malignant melanoma: A study of inter-observer agreement. Am J Clin Pathol 110:753-757, 1998
30. Busam KJ, Antonescu CR, Marghoob AA, et al: Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma: A study of inter-observer agreement. Am J Clin Pathol 115:856-860, 2001
31. National Comprehensive Cancer Network: Melanoma: Clinical practice guidelines in oncology. Available at http://www.nccn.org/professionals/ physician_gls/PDF/melanoma.pdf
32. Breiman L, Friedman JH, Olshen RA, et al: Classification and Regression Trees. Boca Raton, FL, Chapman and Hall, 1984
33. Harrell FE, Lee KL, Califf RM, et al: Regression modeling strategies for improved prognostic prediction. Stat Med 3:143-152, 1984
34. van Houwelingen HC: Validation, calibration, revision and combination of prognostic survival models. Stat Med 19:3401-3415, 2000
35. Clemente CG, Mihm MC Jr, Bufalina R, et al: Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303-1310, 1996
36. Tsao H, Cosimi AB, Sober A: Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer 79:2361-2370, 1997
37. Kalady MF, White RR, Johnson JL, et al: Thin melanomas: Predictive lethal characteristics from a 30-year clinical practice. Ann Surg 238: 528-536, 2003